Elizabeth L Christie

17PUBLICATIONS
196CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumoursSolid tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Oct 20, 2026
Endogenous replication stress creates a unique therapeutic window for ALC1 targeting.

|Aug 06, 2026
Using Polygenic Risk Scores to Refine Risk and Outcomes in High-grade Serous Ovarian Cancer in Australia.

|Apr 01, 2026
Clinicopathologic and molecular predictors of survival in BRCA-deficient tubo-ovarian high-grade serous carcinoma.

Tibor A Zwimpfer, Sian Fereday, Ahwan Pandey

|Nov 19, 2025
Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma.

Dale Garsed, Tibor Zwimpfer, Sian Fereday

|Sep 25, 2025
Exploiting dysregulated iron homeostasis to eradicate persistent high-grade serous ovarian cancer.

Carmelo Cerra, Madeleine R C Tancock, Niko Thio

|Feb 19, 2025
Immunogenic cryptic peptides dominate the antigenic landscape of ovarian cancer.

Remya Raja, Kiran K Mangalaparthi, Anil K Madugundu

Pageof 3

Frequent Collaborators

9 joint publications

Ahwan Pandey

7 joint publications

Dale W Garsed

7 joint publications

Sian Fereday

5 joint publications

Dinuka Ariyaratne